부산대학교 도서관

Robert E; Service de Chirurgie Plastique et des Brûlés, Centre Hospitalier de Mayotte, France.; Beschon R; Service de Médecine Polyvalente, Centre Hospitalier de Mayotte, France.; Robert J; Service BESPIM (Biostatistique, Épidémiologie clinique, Santé Publique et Information Médicale), CHU Nîmes, France.; Le Floch R; Réanimation Chirurgicale et des Brûlés, CHU Nantes, France.; Vernaz S; Service de Réanimation, Centre Hospitalier de Mayotte, France.

Publisher: Mediterranean Council for Burns and Fire Disasters Country of Publication: Italy NLM ID: 101251186 Publication Model: eCollection Cited Medium: Print ISSN: 1592-9558 (Print) Linking ISSN: 15929558 NLM ISO Abbreviation: Ann Burns Fire Disasters Subsets: PubMed not MEDLINE

Ingen-Housz-Oro S; Department of Dermatology, Henri Mondor, AP-HP, Créteil, France; Univ Paris Est Créteil EpiDermE, Créteil, France. Electronic address: saskia.oro@aphp.fr.; Matei I; Department of Dermatology, Henri Mondor, AP-HP, Créteil, France.; Gaillet A; Medical Intensive Care Unit, Henri Mondor Hospital, AP-HP, Créteil, France.; Gueudry J; Department of Ophthalmology, Charles Nicolle University Hospital, Rouen, France.; Zaghbib K; Department of Psychiatry, Henri Mondor Hospital, AP-HP, Créteil, France.; Assier H; Department of Dermatology, Henri Mondor, AP-HP, Créteil, France.; Hua C; Department of Dermatology, Henri Mondor, AP-HP, Créteil, France.; Bensaid B; Department of Dermatology, Edouard Herriot Hospital, Lyon, France.; Colin A; Department of Dermatology, Henri Mondor, AP-HP, Créteil, France.; Ouedraogo R; Medical Intensive Care Unit, Henri Mondor Hospital, AP-HP, Créteil, France.; Redlich J; Department of Dermatology, Henri Mondor, AP-HP, Créteil, France.; Courtois E; Department of Dermatology, Henri Mondor, AP-HP, Créteil, France.; Chazelas K; Department of Dermatology, Henri Mondor, AP-HP, Créteil, France.; Sbidian E; Department of Dermatology, Henri Mondor, AP-HP, Créteil, France; Univ Paris Est Créteil EpiDermE, Créteil, France.; Nakad L; Emergency Department, Henri Mondor Hospital, AP-HP, Créteil, France.; Bequignon E; Department of Otorhinolaryngology, Head and Neck Surgery, Créteil Intercommunal University Hospital, Créteil, France.; Terkmane N; Department of Ophthalmology, Henri Mondor, AP-HP, Créteil, France.; Gaultier F; Department of Oral Medicine and Oral Surgery, Henri Mondor Hospital, AP-HP, Créteil, France.; Schlemmer F; Department of Pneumology, Henri Mondor Hospital, AP-HP, Créteil, France.; Do-Pham G; Department of Internal Medicine, Centre Hospitalier Intercommunal de Créteil, Créteil, France.; Barbaud A; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidemiologie et de Sante Publique, AP-HP Sorbonne Universite, Tenon Hospital, Department of Dermatology and Allergology, Paris, France.; Lebrun-Vignes B; Regional Pharmacovigilance Centre, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, Paris, France.; Hoffmann C; Percy Military Hospital, Burn Center, Clamart, France.; Mahé PJ; Réanimation chirurgicale et des brûlés, PTMC, CHU Nantes, Nantes, France.; Le Floch R; Réanimation chirurgicale et des brûlés, PTMC, CHU Nantes, Nantes, France.; Bernier C; Department of Dermatology, CHU Nantes, Nantes, France.; Vabres B; Department of Ophthalmology, CHU Nantes, Nantes, France.; Milpied B; Department of Dermatology, CHU Bordeaux, Bordeaux, France.; Delcampe A; Department of Ophthalmology, Charles Nicolle University Hospital, Rouen, France.; Tétart F; Department of Dermatology, Charles Nicolle University Hospital, Rouen, France.; Tauber M; Université Lyon 1/INSERM U1111 - CIRI/Hospices Civils de Lyon, Allergologie et Immunologie Clinique, CHU Lyon-Sud, Pierre-Benite France.; Staumont-Sallé D; Department of Dermatology, CHU Lille, Univ Lille, INSERM U1286, Lille Inflammation Translational Research Institute (INFINITE), Lille, France.; Dezoteux F; Department of Dermatology, CHU Lille, Univ Lille, INSERM U1286, Lille Inflammation Translational Research Institute (INFINITE), Lille, France.; Descamps V; Department of Dermatology, Bichat Hospital, AP-HP, Paris, France.; Misery L; Univ Brest, LIEN, Brest, France; University Hospital of Brest, Department of Dermatology, Venereology and Allergology, Brest, France.; Bursztejn AC; Department of Dermatology, CHU Nancy, Nancy, France.; Dereure O; Department of Dermatology, INSERM U1058 « Pathogenesis and Control of Chronic Emerging Infections », University of Montpellier, Montpellier, France.; Amazan E; Department of Dermatology, CHU Martinique, Fort de France, France.; Le Bidre E; Department of Dermatology, University François Rabelais, Hospital of Tours, Tours, France.; Le Pallec S; Patients' Association AMALYSTE, Paris, France.; Lagier C; Patients' Association AMALYSTE, Paris, France.; Laroche A; Patients' Association AMALYSTE, Paris, France.; Ferrat E; University Paris-Est Créteil, INSERM, IMRB, Equipe CEpiA, Créteil, France.; Wolkenstein P; Department of Dermatology, Henri Mondor, AP-HP, Créteil, France; University Paris-Est Créteil, UPEC, Créteil, France.; de Prost N; Medical Intensive Care Unit, Henri Mondor Hospital, AP-HP, Créteil, France; University Paris-Est Créteil, UPEC, Créteil, France.

Publisher: Masson Country of Publication: France NLM ID: 7702013 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 0151-9638 (Print) Linking ISSN: 01519638 NLM ISO Abbreviation: Ann Dermatol Venereol Subsets: MEDLINE

Brüggen MC; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Christine Kühne Center for Allergy Research and Education, Davos, Switzerland.; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Le ST; Department of Dermatology, University of California, Davis, Sacramento, CA, USA.; Walsh S; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Department of Dermatology, King's College Hospital, London, UK.; Toussi A; Department of Dermatology, University of California, Davis, Sacramento, CA, USA.; de Prost N; Intensive Care Unit, AP-HP, Henri Mondor Hospital, Créteil, France.; Toxic Bullous Dermatoses TOXIBUL Reference Centre, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.; Ranki A; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Department of Skin and Allergic Diseases, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.; Didona B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; First Dermatology Division, Institute Dermopatico dell'Immacolata (I.D.I.) - IRCCS, Via Monti di Creta 104, Rome, 00167, Italy.; Colin A; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Toxic Bullous Dermatoses TOXIBUL Reference Centre, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.; Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.; Horváth B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Department of Dermatology, Center for Blistering Diseases, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Brezinova E; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Department of Dermatovenereology, St Ann's University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic.; Milpied B; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Toxic Bullous Dermatoses TOXIBUL Reference Centre, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, CHU Bordeaux, Bordeaux, France.; Moss C; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Birmingham Children's Hospital and University of Birmingham, Birmingham, UK.; Bodemer C; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Toxic Bullous Dermatoses TOXIBUL Reference Centre, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, AP-HP, Necker Hospital, Paris, France.; Meyersburg D; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Department of Dermatology and Allergology, University Hospital Salzburg of the Paracelsus Medical University Salzburg, Salzburg, Austria.; Salavastru C; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Department of Paediatric Dermatology, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Tiplica GS; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Department of Dermatology II, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.; Howard E; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Birmingham Children's Hospital and University of Birmingham, Birmingham, UK.; Bequignon E; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Department of Otorhinolaryngology and Head and Neck Surgery, AP-HP, Henri Mondor Hospital, Créteil, France.; Bouwes Bavinck JN; Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands.; Newman J; Macmillan Skin Cancer CNS, Normanby Building, Denmark Hill, London, UK.; Gueudry J; Toxic Bullous Dermatoses TOXIBUL Reference Centre, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.; Ophthalmology Department, Hospital Charles Nicolle, EA7510, UFR Santé, Rouen University, Rouen, France.; Nägeli M; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.; Zaghbib K; Toxic Bullous Dermatoses TOXIBUL Reference Centre, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Psychiatry, AP-HP, Henri Mondor-Albert Chenevier Hospitals, Cr, France.; Pallesen K; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Department of Dermatology, Aarhus University Hospital, Palle Juul-Jensens, Aarhus, Denmark.; Bygum A; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Clinical Institute, University of Southern Denmark, Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.; Joly P; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Toxic Bullous Dermatoses TOXIBUL Reference Centre, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.; Department of Dermatology, CHU Charles, Nicolle, Rouen, France.; Wolkenstein P; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Toxic Bullous Dermatoses TOXIBUL Reference Centre, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.; Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.; Chua SL; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Queen Elizabeth Hospital Birmingham, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.; Le Floch R; Toxic Bullous Dermatoses TOXIBUL Reference Centre, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.; Réanimation Chirurgicale et des Brûlés, PTMC, CHU Nantes, Nantes, France.; Shear NH; Division of Clinical Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Chu CY; Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Hama N; Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.; Abe R; Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.; Chung WH; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.; Shiohara T; Department of Dermatology, Kyorin University School of Medicine, Tokyo, Japan.; Ardern-Jones M; Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Romanelli P; Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.; Phillips EJ; Department of Medicine & Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.; Stern RS; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Cotliar J; Science 37, Los Angeles, CA, USA.; Micheletti RG; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Brassard A; Department of Dermatology, University of California, Davis, Sacramento, CA, USA.; Schulz JT; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Dodiuk-Gad RP; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Dominguez AR; Department of Dermatology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Paller AS; Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Seminario-Vidal L; Department of Dermatology, University of South Florida, Cutaneous Oncology Program, Moffitt Cancer Center, Tampa, FL, USA.; Mostaghimi A; Department of Dermatology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.; Noe MH; Department of Dermatology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.; Worswick S; Keck-USC School of Medicine, Los Angeles, CA, USA.; Tartar D; Department of Dermatology, University of California, Davis, Sacramento, CA, USA.; Sheridan R; Burn Surgery Service, Shriners Burns Hospital, Sumner Redstone Burn Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Kaffenberger BH; Division of Dermatology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA.; Shinkai K; Department of Dermatology, University of California, San Francisco, CA, USA.; Maverakis E; Department of Dermatology, University of California, Davis, Sacramento, CA, USA.; French LE; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Department of Dermatology and Allergy, University Hospital of Munich, LMU, Munich, Germany.; Ingen-Housz-Oro S; ToxiTEN Group, European Reference Network for Rare Skin Diseases (ERN-skin), Paris, France.; Toxic Bullous Dermatoses TOXIBUL Reference Centre, Filière FIMARAD, AP-HP, Henri Mondor Hospital, Créteil, France.; Dermatology Department, AP-HP, Henri Mondor Hospital, Créteil, France.; Universit, EpiDermE, Créteil, France.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

Ingen-Housz-Oro S; Service de dermatologie, AP-HP, hôpital Henri Mondor, Créteil, France.; EA7379 EpidermE, UPEC, Créteil, France.; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Le Floch R; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Réanimation chirurgicale et des brûlés, PTMC, CHU Nantes, Nantes, France.; Alves A; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Réanimation médicale, AP-HP, hôpital Henri Mondor, Créteil, France.; Colin A; Service de dermatologie, AP-HP, hôpital Henri Mondor, Créteil, France.; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Ouedraogo R; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Réanimation médicale, AP-HP, hôpital Henri Mondor, Créteil, France.; Welfringer A; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Service de dermatologie, AP-HP, hôpital Necker, Paris, France.; Dereure O; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Service de dermatologie, Université de Montpellier, Montpellier, France.; Besnard N; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Département de Médecine Intensive et Réanimation, Hôpital Lapeyronie, Montpellier, France.; Bodemer C; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Service de dermatologie, AP-HP, hôpital Necker, Paris, France.; Bernier C; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Service de dermatologie, CHU Nantes, Nantes, France.; Hoffmann C; Centre de Traitement des Brûlés, Hôpital d'Instruction des Armées PERCY, Clamart, France.; Tétart F; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Service de dermatologie, CHU Charles Nicolle, Rouen, France.; Carpentier D; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Réanimation médicale, CHU Charles Nicolle, Rouen, France.; Cordel N; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Unité de dermatologie et immunologie clinique, CHU Guadeloupe, Pointe-à-Pitre, France.; Elie E; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Centre de traitement des brûlés, CHU de Guadeloupe, Pointe-à-Pitre, France.; Tauber M; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Service de dermatologie, CHU de Toulouse, Toulouse, France.; Soubiron L; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; CFXM-Brûlés, Service d'anesthésie Réanimation, GH Pellegrin, Bordeaux, France.; Milpied B; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Service de dermatologie, hôpital Saint-André, Bordeaux, France.; de Prost N; Centre de référence dermatoses bulleuses toxiques et toxidermies graves TOXIBUL, Créteil, France.; Réanimation médicale, AP-HP, hôpital Henri Mondor, Créteil, France.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE

Sutton, K M; Hayat, S; Chau, N-M; Cook, S; Pouyssegur, J; Ahmed, A; Perusinghe, N; Le Floch, R; Yang, J; Ashcroft, M

Oncogene. Jun 07, 2007 26(27):3920-3929

Xiong, Y. Q.; Caillon, J.; Zhou, X. Y.; Potel, G.; Bugnon, D.; Conte, P. Le; Gallou, F. Le; Floch, R. Le; Baron, D.; Drugeon, H.; Le Conte, P; Le Gallou, F; Le Floch, R

Journal of Antimicrobial Chemotherapy (JAC); May1995, Vol. 35 Issue 5, p697-706, 10p

Le Floch R; Réanimation Chirurgicale et des Brûlés, CHU Nantes, France.; Lancien U; Service des Brûlés, CHU Nantes, France.; Mauduit N; Service d'Information Médicale, CHU Nantes, France.; Mahé PJ; Réanimation Chirurgicale et des Brûlés, CHU Nantes, France.; Perrot P; Service des Brûlés, CHU Nantes, France.

Publisher: Mediterranean Council for Burns and Fire Disasters Country of Publication: Italy NLM ID: 101251186 Publication Model: eCollection Cited Medium: Print ISSN: 1592-9558 (Print) Linking ISSN: 15929558 NLM ISO Abbreviation: Ann Burns Fire Disasters Subsets: PubMed not MEDLINE